The exact sequence and timing can vary, and interim policies may affect FDAs enforcement approach while the formal list is under development
People are overdosing on injectable weight-loss drugs, FDA warns Some people are overdosing from certain products marketed for weight loss, federal health officials are warning
Clinical use of psyllium husk in the treatment of constipation and diarrhea
Tirzepatide (Mounjaro, Zepbound) is an FDA-approved once-weekly injection for type 2 diabetes and chronic weight management
They recommend a one-week onboarding: one capsule daily for two days, then one capsule twice daily for two days, then up to two small capsules twice daily
Accessing GLP-1 receptor agonists specifically for fatty liver disease on the NHS can be challenging, as current prescribing pathways are primarily designed for diabetes and weight management rather than liver disease alone